The Islets Biology department currently consists of approximately 40 dedicated people comprising scientists, research technicians, students and 12 islet fishers.
Our objective includes:
Identify new targets to treat or prevent diabetes by reconstituting functional beta cell mass. We identify, investigate and translate protein targets that can induce beta cell regeneration and we study process of beta cell neogenesis and replication using state-of-art technologies.
Further develop and implement In Vitro Islet assay’s like GSIS, replication, apoptosis & neogenesis and make them available for projects in the pipeline.
Isolate Islet cells from primarily rodents, characterize Islet cell lines and make all available for the organization.
|
To deliver drug candidates to treat or prevent diabetes by reconstitution of functional beta-cell mass and to develop & service the pipeline with In Vitro Islet assay’s like GSIS.
